![Follow Forum_Psych on Twitter](https://2img.net/h/twitter-badges.s3.amazonaws.com/follow_us-a.png)
Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
![Share](https://2img.net/h/static.addtoany.com/buttons/share_save_171_16.png)
CME: Schizophrenia- Translating Science into Clinical Practice
Page 1 of 1
CME: Schizophrenia- Translating Science into Clinical Practice
CME: Schizophrenia- Translating Science into Clinical Practice
![CME: Schizophrenia- Translating Science into Clinical Practice Iss_sc10](https://i.servimg.com/u/f40/16/20/97/79/iss_sc10.jpg)
Credits: 1.5
Release Date: December 27, 2011
Expiration Date: December 27, 2012
Faculty
Jon W. Draud, MS, MD
Medical Director of Psychiatry & Addiction Medicine
Baptist Hospital
Nashville, TN
Middle Tennessee medical Center
Murfreesboro, TN
Gregory W. Mattingly, MD
Associate Clinical Professor
Washington University School of Medicine
Saint Charles, MO
Joseph Sharpe, MD
Psychiatric Hospitalist
Saint Thomas Healthcare System
Medical Director of Psychiatry
Cumberland Heights Alcohol & Drug Treatment Center
Nashville, TN
Credit Designation
CME LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion, as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.
Goal Statement
The goal of this activity is to assist mental healthcare professionals in meeting the challenges of the management of schizophrenia by providing evidence-based rationale and strategies to use in practice that improve patient outcomes and quality of life.
Learning Objectives
After completing this activity, participants should be able to:
- Evaluate the mechanism of action and side effects of commonly used antipsychotics to improve the individualized treatment of this disorder
- Determine strategies for continuous monitoring of medication adherence in order to reduce the risk of relapse
- Discuss how and when to switch and augment therapy to optimize the long-term care of patients with schizophrenia
Target Audience
This continuing medical education activity is intended for psychiatrists and other healthcare professionals who seek to improve their care for patients with schizophrenia and the outcomes resulting from that care.
Click here to attend the CME: http://www.cmellc.com/CMEActivities/tabid/54/ctl/ActivityController/mid/545/activityid/2369/Default.aspx
![CME: Schizophrenia- Translating Science into Clinical Practice Iss_sc10](https://i.servimg.com/u/f40/16/20/97/79/iss_sc10.jpg)
Credits: 1.5
Release Date: December 27, 2011
Expiration Date: December 27, 2012
Faculty
Jon W. Draud, MS, MD
Medical Director of Psychiatry & Addiction Medicine
Baptist Hospital
Nashville, TN
Middle Tennessee medical Center
Murfreesboro, TN
Gregory W. Mattingly, MD
Associate Clinical Professor
Washington University School of Medicine
Saint Charles, MO
Joseph Sharpe, MD
Psychiatric Hospitalist
Saint Thomas Healthcare System
Medical Director of Psychiatry
Cumberland Heights Alcohol & Drug Treatment Center
Nashville, TN
Credit Designation
CME LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion, as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.
Goal Statement
The goal of this activity is to assist mental healthcare professionals in meeting the challenges of the management of schizophrenia by providing evidence-based rationale and strategies to use in practice that improve patient outcomes and quality of life.
Learning Objectives
After completing this activity, participants should be able to:
- Evaluate the mechanism of action and side effects of commonly used antipsychotics to improve the individualized treatment of this disorder
- Determine strategies for continuous monitoring of medication adherence in order to reduce the risk of relapse
- Discuss how and when to switch and augment therapy to optimize the long-term care of patients with schizophrenia
Target Audience
This continuing medical education activity is intended for psychiatrists and other healthcare professionals who seek to improve their care for patients with schizophrenia and the outcomes resulting from that care.
Click here to attend the CME: http://www.cmellc.com/CMEActivities/tabid/54/ctl/ActivityController/mid/545/activityid/2369/Default.aspx
![-](https://2img.net/i/empty.gif)
» How DSM-5 Will Change Your Clinical Practice
» Vitamins & Supplements in Clinical Practice.
» Effectiveness of Transcranial Magnetic Stimulation in Clinical Practice Post-FDA Approval
» Clinical Case Query (2)
» Clinical Vignette: What is the cause of Nausea & Vomiting?
» Vitamins & Supplements in Clinical Practice.
» Effectiveness of Transcranial Magnetic Stimulation in Clinical Practice Post-FDA Approval
» Clinical Case Query (2)
» Clinical Vignette: What is the cause of Nausea & Vomiting?
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
» L-Methylfolate: Who Will benefit
» Vitamins & Supplements in Clinical Practice.
» Imaging Biomarkers for Outcomes in Mild TBI
» Q.5 Clozapine Neutopenia
» Treating Disorders!
» Cortical Abnormalities in Adults & Adolescents with MDD
» Efficacy of Antipsychotics in Pediatric Acute Mania
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?